GlassScriptPhysician profile
Amar Hirendra Doshi
NPI 1144607581
$6,489.63
in general payments reported to CMS, 2019-2025
19 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $1,448 · 2021: $157 · 2022: $107 · 2023: $1,410 · 2024: $1,647 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.79 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,076.35 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $1,049.57 | 2023-2025 | Barostim Neo System |
| United Therapeutics Corporation | $530.44 | 2023-2025 | Remodulin, Tyvaso |
| Kestra Medical Technology Services, INC. | $459.30 | 2023-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $417.72 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $169.50 | 2021-2023 | Farxiga |
| Impulse Dynamics (USA) INC. | $156.88 | 2023 | Optimizer |
| Boston Scientific Corporation | $141.08 | 2024 | Exalt Model D |
| Micro-Tech Endoscopy USA, INC. | $109.14 | 2023 | Dat Closure Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.30 | 2024-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $75.32 | 2023 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $42.01 | 2023-2025 | |
| Picard Medical INC. | $37.52 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.88 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $23.62 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $22.19 | 2022 | |
| Cardiovascular Systems INC. | $20.79 | 2021 | |
| Philips North America LLC | $16.71 | 2020 | |
| Medtronic, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.